Market revenue in 2022 | USD 1,317.6 million |
Market revenue in 2030 | USD 2,530.5 million |
Growth rate | 8.5% (CAGR from 2022 to 2030) |
Largest segment | Transmitter & receiver |
Fastest growing segment | Insulin Pumps |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sensors, Transmitter & Receiver, Insulin Pumps |
Key market players worldwide | DexCom Inc, Abbott Laboratories, Medtronic PLC, Ypsomed Holding AG, Senseonics Holdings Inc, A.Menarini Diagnostics, Signos |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous glucose monitoring devices market will help companies and investors design strategic landscapes.
Transmitter & receiver was the largest segment with a revenue share of 36.9% in 2022. Horizon Databook has segmented the U.S. continuous glucose monitoring devices market based on sensors, transmitter & receiver, insulin pumps covering the revenue growth of each sub-segment from 2018 to 2030.
In North America, the U.S. dominated the market in 2023 due to a large diabetic population and favorable reimbursement policies. The high per capita income and increasing healthcare spending are among the key factors likely to drive market growth.
The American Diabetes Association released the Economic Costs of Diabetes in the U.S. report in November 2023, highlighting the economic impact of diabetes in 2022.The report also mentioned that individuals diagnosed with diabetes now contribute to one-fourth of all healthcare expenses in the U.S.
Furthermore, the adoption of smart devices and technological advancements, such as the use of AI & data analytics, are propelling market growth. In addition, Abbott, Medtronic, and Dexcom are some of the key players operating in the U.S. CGM devices market.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. continuous glucose monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. continuous glucose monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account